Human lung small-cell carcinoma contains bombesin.

Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc Natl Acad Sci U S A (1983) 3.09

Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci U S A (1984) 1.93

Protein kinase C-mediated negative-feedback inhibition of unstimulated and bombesin-stimulated polyphosphoinositide hydrolysis in Swiss-mouse 3T3 cells. Biochem J (1987) 1.51

High-affinity receptors for peptides of the bombesin family in Swiss 3T3 cells. Proc Natl Acad Sci U S A (1985) 1.43

Early phosphorylation events following the treatment of Swiss 3T3 cells with bombesin and the mammalian bombesin-related peptide, gastrin-releasing peptide. EMBO J (1986) 1.38

Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding. J Cell Biol (1986) 1.30

Transient elevation of messenger RNA encoding gastrin-releasing peptide, a putative pulmonary growth factor in human fetal lung. J Clin Invest (1987) 1.29

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro. Proc Natl Acad Sci U S A (1988) 1.21

Somatostatin and analogues in the treatment of cancer. A review. Ann Surg (1991) 1.11

Receptor for bombesin with associated tyrosine kinase activity. Mol Cell Biol (1986) 1.08

A peptide that inhibits the mitogenic stimulation of Swiss 3T3 cells by bombesin or vasopressin. Biochem J (1985) 1.03

Neuropeptide stimulation of calcium flux in human lung cancer cells: delineation of alternative pathways. Proc Natl Acad Sci U S A (1990) 0.99

Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids. Am J Pathol (1991) 0.91

Gastrin-releasing peptide, a mammalian analog of bombesin, is present in human neuroendocrine lung tumors. Am J Pathol (1984) 0.91

Internalization and degradation of peptides of the bombesin family in Swiss 3T3 cells occurs without ligand-induced receptor down-regulation. EMBO J (1987) 0.88

A rhesus monkey model to characterize the role of gastrin-releasing peptide (GRP) in lung development. Evidence for stimulation of airway growth. J Clin Invest (1994) 0.87

Immunohistochemical techniques and their applications in the histopathology of the respiratory system. Environ Health Perspect (1984) 0.84

Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase. Br J Cancer (1996) 0.84

A bombesin immunoreactive peptide in milk. Proc Natl Acad Sci U S A (1984) 0.83

Isolation and sequence of a cDNA encoding the precursor of a bombesinlike peptide from brain and early embryos of Xenopus laevis. Proc Natl Acad Sci U S A (1992) 0.82

Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors. Am J Pathol (1988) 0.82

Bombesin receptor in membranes from Swiss 3T3 cells. Binding characteristics, affinity labelling and modulation by guanine nucleotides. Biochem J (1990) 0.82

Characterization of the high-affinity receptors on Swiss 3T3 cells which mediate the binding, internalization and degradation of the mitogenic peptide bombesin. Biochem J (1988) 0.80

Autocrine growth factors and solid tumor malignancy. West J Med (1991) 0.80

Activation of the protein-tyrosine kinase associated with the bombesin receptor complex in small cell lung carcinomas. Proc Natl Acad Sci U S A (1988) 0.79

Co-secretion of calcitonin gene-related peptide, gastrin-releasing peptide and ACTH by a carcinoid tumour metastasizing to the cerebellum. Postgrad Med J (1987) 0.78

Neuropeptide growth factors and cancer. Br J Cancer (1991) 0.78

Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer. Br J Cancer (1988) 0.77

Studying lung cancer in the laboratory: 3--Use of cell lines to investigate the biology of lung cancer. Thorax (1987) 0.75

ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY. Science (1964) 4.93

A silver nitrate stain for alpha-2 cells in human pancreatic islets. Acta Soc Med Ups (1968) 3.93

Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16

Transplantation of human tumors in nude mice. J Natl Cancer Inst (1976) 2.13

High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science (1981) 2.07

Bifunctional reagents as vapour- and liquid-phase fixatives for immunohistochemistry. Histochem J (1975) 1.80

Bombesin-like immunoreactivity in the lung. Nature (1978) 1.73

Ectopic ACTH production in carcinoma of the lung. J Clin Invest (1974) 1.65

The neuronal origin of bombesin-like immunoreactivity in the rat gastrointestinal tract. Neuroscience (1979) 1.56

Current concepts in cancer: small-cell lung cancer. N Engl J Med (1979) 1.37

Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A (1978) 1.30

Bombesin, somatostatin and neurotensin-like immunoreactivity in bronchial carcinoma. J Clin Endocrinol Metab (1981) 1.28

In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues. J Clin Invest (1976) 1.25

Bombesin-like peptides in mammals. Fed Proc (1979) 1.24

Placental proteins and their subunits as tumor markers. Ann Intern Med (1975) 1.22

Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung. A clinicopathologic study. Am J Med (1979) 1.22

Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture. Cancer Res (1980) 1.21

Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications. Endocr Rev (1980) 1.20

Distribution of a bombesin-like peptide in human gastrointestinal tract. Lancet (1976) 1.20

In vitro action of bombesin on amylase secretion, membrane potential, and membrane resistance in rat and mouse pancreatic acinar cells. A comparison with other secretagogues. J Clin Invest (1978) 1.20

Multiple hormones in a bronchial tumor. J Clin Endocrinol Metab (1974) 1.09

Diethylpyrocarbonate, a vapour-phase fixative for immunofluorescence studies on polypeptide hormones. Histochem J (1974) 1.08

High potency of bombesin for stimulation of human gastrin release and gastric acid secretion. Regul Pept (1981) 1.07

Mast cell binding of neurotensin. I. Iodination of neurotensin and characterization of the interaction of neurotensin with mast cell receptor sites. J Biol Chem (1977) 1.05

Bombesin-like activity: radioimmunologic assessment in biological tissues. Life Sci (1978) 1.05

Effect of bombesin infused intrapancreatically on glucagon and insulin secretion. Metabolism (1978) 1.03

The effect of bombesin and related peptides on prolactin and growth hormone secretion in the rat. Endocrinology (1978) 0.95

A neuropeptide in mammalian tissues with physalaemin-like immunoreactivity. Nature (1980) 0.89

Effect of bombesin-stimulated gastrin on gastric acid secretion in man. Life Sci (1980) 0.89

Substance P sulfoxide: separation from substance P by high-pressure liquid chromatography, biological and immunological activities, and chemical reduction. Anal Biochem (1980) 0.88

Bombesin stimulates the release of insulin and glucagon, but not pancreatic somatostatin, from the isolated perfused dog pancreas. Endocr Res Commun (1979) 0.88

Ectopic and eutopic secretion of chorionic gonadotropin and its sub-nits in vitro: comparison of clonal strains from carcinomas of lung and placenta. J Natl Cancer Inst (1976) 0.86

Bombesin-like peptide in hypothalamus: chemical and immunological characterization. Life Sci (1978) 0.84

A new in vitro cell line established from human oat cell carcinoma of the lung. Cancer Res (1977) 0.82

Application of a sequence-specific radioimmunoassay for the carboxyl-terminal region of corticotropin. Clin Chem (1981) 0.81

Bombesin-like peptides in rat brain: localization in synaptosomes and release from hypothalamic slices. Life Sci (1980) 0.79

Radioimmunoassay for the tachykinin peptide physalaemin: detection of a physalaemin-like substance in rabbit stomach. Anal Biochem (1980) 0.78

Plasma immunoreactive calcitonin in lung cancer. Endocr Res Commun (1979) 0.78

Concepts in ectopic hormone production. Clin Endocrinol (Oxf) (1976) 0.78

Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol (1991) 3.59

NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl (1996) 3.24

p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene (1992) 2.64

Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol Cell Biol (1985) 2.49

A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol (2000) 2.35

An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature (1997) 2.29

Simplified adaptor for electroelution. Anal Biochem (1971) 2.19

Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest (1983) 2.12

Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res (1992) 1.86

beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. Proc Natl Acad Sci U S A (1976) 1.79

Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene (1991) 1.79

Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med (1993) 1.66

Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies. Mol Cell Biol (1984) 1.66

Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest (1999) 1.58

Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis. Exp Lung Res (2000) 1.58

Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci U S A (1991) 1.50

Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung. Cancer (1999) 1.49

Scientific basis for cancer prevention. Intermediate cancer markers. Cancer (1993) 1.47

Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial. J Natl Cancer Inst (1990) 1.42

Letter: Synthesis of (+/-)-7 beta,8alpha-dihydroxy-9 beta,10beta-epoxy-7,8,-9,10-tetrahydrobenzo(a)pyrene, a potential metabolite of the carcinogen benzo(a)pyrene with stereochemistry related to the antileukemic triptolides. J Am Chem Soc (1975) 1.38

Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ (1998) 1.37

Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem (1997) 1.36

Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides. Cancer Res (1976) 1.29

High mutagenicity and toxicity of a diol epoxide derived from benzo(a)pyrene. Biochem Biophys Res Commun (1976) 1.26

Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res (1988) 1.24

p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res (1993) 1.23

Viscosity-density gradient for purification of foot-and-mouth disease virus. Arch Gesamte Virusforsch (1972) 1.22

Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabeling analysis. Carcinogenesis (1990) 1.22

Expression of CD44 in human lung tumors. Cancer Res (1994) 1.18

Synthesis and reactions of the highly mutagenic 7,8-diol 9,10-epoxides of the carcinogen benzo[a]pyrene. J Am Chem Soc (1977) 1.17

Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children. Hum Pathol (1984) 1.17

Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene (2011) 1.17

Lung concentric laminar organelle. Hydrolase activity and compositional analysis. J Biol Chem (1974) 1.15

Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. J Biol Chem (1976) 1.14

Neuroendocrine cells and neuroendocrine neoplasms of the lung. Pathol Annu (1983) 1.13

Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. J Med Chem (1999) 1.11

Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma. Br J Cancer (1985) 1.11

Distribution of [Met5]- and [Leu5]-enkephalin-, vasoactive intestinal polypeptide- and substance P-like immunoreactivities in human adrenal glands. Neuroscience (1980) 1.11

Letter: Cytoplasmic DNA polymerase: polymeric forms and their conversion into an active monomer resembling nuclear DNA polymerase. J Mol Biol (1973) 1.11

Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. J Natl Cancer Inst Monogr (1992) 1.08

The pathology of lung cancer--changing concepts and newer diagnostic techniques. Semin Oncol (1988) 1.08

Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus. Proc Natl Acad Sci U S A (1996) 1.08

Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res (1990) 1.07

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol (1994) 1.07

Mast cell binding of neurotensin. I. Iodination of neurotensin and characterization of the interaction of neurotensin with mast cell receptor sites. J Biol Chem (1977) 1.05

Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells. Cancer Res (1976) 1.05

Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity. J Med Chem (1997) 1.05

MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res (1998) 1.04

Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia (2002) 1.04

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol (1996) 1.02

Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res (1994) 1.02

Altered cJUN expression: an early event in human lung carcinogenesis. Cancer Res (1996) 1.02

An immunohistochemical and radioimmunological study of the distribution of [met5]- and [leu5]-enkephalin in the gastrointestinal tract. Neuroscience (1978) 1.01

The effects of a continuing medical education programme in interpersonal communication skills on doctor practice and patient satisfaction in Trinidad and Tobago. Med Educ (1998) 1.01

Hepatic lipid droplets. Isolation, morphology and composition. Biochem J (1973) 1.01

Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. J Clin Oncol (1990) 1.01

A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Cancer Res (1990) 1.00

Lipids found in pulmonary lavage of patients with alveolar proteinosis and in rabbit lung lamellar organelles. Am Rev Respir Dis (1976) 0.99

Association of foot-and-mouth disease virus replicase with RNA template and cytoplasmic membranes. J Gen Virol (1974) 0.99

Advances in uterine leiomyoma research: conference overview, summary, and future research recommendations. Environ Health Perspect (2000) 0.98

Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region ("Askin tumor"). Am J Surg Pathol (1986) 0.98

myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Cancer Res (1991) 0.97

Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol (1995) 0.96

Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers. Am J Respir Cell Mol Biol (1993) 0.94

Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse. J Biol Chem (1998) 0.94

A role for phospholipids in the binding and metabolism of drugs by hepatic microsomes. Use of the fluorescent hydrophobic probe 1-anilinonaphthalene-8-sulphonate. Biochem J (1971) 0.94

Isolation and characterization of two hydroxyproline-containing glycoproteins from normal animal lung lavage and lamellar bodies. J Clin Invest (1975) 0.94

Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol (1997) 0.94

Selective opioid dipeptides. Biochem Biophys Res Commun (1994) 0.94

Pacemaker implantation in familial congenital A-V block complicated by Adams-Stokes attacks. Br Heart J (1967) 0.93

Purification and properties of an oestrogen-stimulated mouse uterine glycoprotein (approx. 70 kDa). Biochem J (1986) 0.93

Attenuation of pulmonary neuroendocrine differentiation in mice lacking Clara cell secretory protein. Lab Invest (2000) 0.93

Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors. J Pharmacol Exp Ther (2004) 0.93

Expression of epidermal growth factor in suprabasal cells of stratified squamous epithelia: implications for a role in differentiation. Cell Growth Differ (1994) 0.93

Proliferation of mouse uterine epithelial cells in vitro. Endocrinology (1986) 0.92

Gastrin-releasing peptide gene-associated peptides are expressed in normal human fetal lung and small cell lung cancer: a novel peptide family found in man. J Clin Endocrinol Metab (1988) 0.92

Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium. Lung Cancer (1996) 0.92

Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ (1998) 0.92

Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines. J Natl Cancer Inst (1990) 0.91

Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab Invest (1992) 0.91

An evaluation of the impact of training Honduran health care providers in interpersonal communication. Int J Qual Health Care (2000) 0.90

Inhibition and dissociation of mammalian polymeric DNA polymerase by heparin. Arch Biochem Biophys (1974) 0.90

Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival. Br J Cancer (2010) 0.89

A neuropeptide in mammalian tissues with physalaemin-like immunoreactivity. Nature (1980) 0.89

Histochemical characterization of non-neuroendocrine tumors and neuroendocrine cell hyperplasia induced in hamster lung by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone with or without hyperoxia. Am J Pathol (1995) 0.88

Epidermal growth factor precursor in mouse lactating mammary gland alveolar cells. Mol Endocrinol (1989) 0.88

Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res (1993) 0.87

K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer. Br J Cancer (1998) 0.87

Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers. Int J Cancer (1992) 0.87

Clara cell 10 kDa protein mRNA in normal and atypical regions of human respiratory epithelium. Int J Cancer (1994) 0.87

Ventriculoperitoneal shunts in children on peritoneal dialysis: a survey of the International Pediatric Peritoneal Dialysis Network. Pediatr Nephrol (2012) 0.87

A novel system for DNA synthesis in isolated nuclei. FEBS Lett (1973) 0.86

Na+ mechanism of delta-opioid receptor induced protection from anoxic K+ leakage in the cortex. Cell Mol Life Sci (2009) 0.86

Bronchiolization of the alveoli in lung cancer: pathology, patterns of differentiation and oncogene expression. Int J Cancer (1998) 0.86

Neurotensin analogues. Structure--activity relationships. J Med Chem (1977) 0.86

Mast cell binding of neurotensin. II. Molecular conformation of neurotensin involved in the stereospecific binding to mast cell receptor sites. J Biol Chem (1977) 0.86